Hiroshi Ueda

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

Part of Sumitomo Chemical Co., Ltd., CDT Holdings Ltd. provides professional, scientific and technical services. The private company is based in Godmanchester, UK.

Cambridge Display Technology ltd. develops display technologies based on polymer organic light emitting diodes (P-OLEDs). It primarily focuses on developing P-OLEDs for display and lighting applications, as well as organic semiconductor and photovoltaic applications. The firm specializes in the areas of materials development, device optimization and modeling, manufacturing processes, and intellectual property. The company was founded by Richard Friend, Jeremy Burroughes, and Donal Donat Conor Bradley on January 2, 1992 and is headquartered in Godmanchester, the United Kingdom.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Part of Sumitomo Chemical Co., Ltd., CDT Holdings Ltd. provides professional, scientific and technical services. The private company is based in Godmanchester, UK.

Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura.

Cambridge Display Technology ltd. develops display technologies based on polymer organic light emitting diodes (P-OLEDs). It primarily focuses on developing P-OLEDs for display and lighting applications, as well as organic semiconductor and photovoltaic applications. The firm specializes in the areas of materials development, device optimization and modeling, manufacturing processes, and intellectual property. The company was founded by Richard Friend, Jeremy Burroughes, and Donal Donat Conor Bradley on January 2, 1992 and is headquartered in Godmanchester, the United Kingdom.

Cambridge Display Technology ltd. develops display technologies based on polymer organic light emitting diodes (P-OLEDs). It primarily focuses on developing P-OLEDs for display and lighting applications, as well as organic semiconductor and photovoltaic applications. The firm specializes in the areas of materials development, device optimization and modeling, manufacturing processes, and intellectual property. The company was founded by Richard Friend, Jeremy Burroughes, and Donal Donat Conor Bradley on January 2, 1992 and is headquartered in Godmanchester, the United Kingdom.

Part of Sumitomo Chemical Co., Ltd., Sumika Chemical Analysis Service Ltd. was founded in 1972 and is a general analysis company based in Osaka, Japan. The Japanese company provides registration application services for chemical regulations and application support services necessary for manufacturing, selling, and exporting pharmaceuticals and medical equipment. The private company strategically consults necessary exams during the registration process and offer evaluation and analysis of various raw materials and products, environmental surveys, risk management support, and consultancy services for research and development, application, manufacturing, and sales of pharmaceuticals.